JSC "VALENTA PHARM"

🇷🇺Russia

Country: 🇷🇺Russia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Safety, Tolerability, and Pharmacokinetic Parameters of Grammidin With Anesthetic, a Metered Spray in Healthy Volunteers

Phase 1

Recruiting

Conditions: Pharyngitis

Interventions: Drug: Grammidin with anesthetic neo
Drug: Grammidin with anesthetic, a metered spray for local application

First Posted Date: 2025-03-05

Last Posted Date: 2025-03-05

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 24

Registration Number: NCT06857890

Locations: 🇷🇺
Separate Medical Unit "CoMed" (LLC "Ligand Research"), Moscow, Russian Federation

Safety, Tolerability, and Pharmacokinetic Parameters of Grammidin, a Metered Spray in Healthy Volunteers

Phase 1

Recruiting

Conditions: Pharyngitis

Interventions: Drug: Grammidin neo
Drug: Grammidin, a metered spray for local application

First Posted Date: 2025-03-05

Last Posted Date: 2025-03-05

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 24

Registration Number: NCT06859281

Locations: 🇷🇺
Limited Liability Company "Research Center Eco-Safety", Saint Petersburg, Russian Federation

Safety, Tolerability, and Pharmacokinetic Parameters of Increasing Doses of Ingavirin Forte, Capsules, During Single and Subsequent Multiple Oral Administration in Healthy Volunteers

Phase 1

Recruiting

Conditions: Influenza
Viral Respiratory Infection

Interventions: Drug: Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid, 90 mg + 5 mg
Drug: Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid, 90 mg + 10 mg
Drug: Combined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid, 90 mg + 20 mg

First Posted Date: 2025-03-05

Last Posted Date: 2025-03-05

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 36

Registration Number: NCT06859333

Locations: 🇷🇺
State Budgetary Healthcare Institution of the City of Moscow "City Clinical Hospital No. 15 named after O.M. Filatov of the Department of Health of Moscow.", Moscow, Russian Federation

Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adaptation Disorders

Phase 4

Recruiting

Conditions: Anxiety
Neurasthenia
Adaptation Abnormal

Interventions: Drug: Ranquilon
Drug: Afobazole

First Posted Date: 2025-02-24

Last Posted Date: 2025-03-04

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 250

Registration Number: NCT06843044

Locations: 🇷🇺
Engels Psychiatric Hospital State Health Care Institution of the Ministry of Health of the Saratov Region, Engels, Russian Federation
🇷🇺
Unimed-C Jsc, Moscow, Russian Federation
🇷🇺
Aurora MedFort LLC, Saint Petersburg, Russian Federation

and more 3 locations

Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia

Phase 2

Recruiting

Conditions: Chronic Cholecystitis
Biliary Dyskinesia

Interventions: Drug: 4-MUST
Drug: Placebo

First Posted Date: 2025-02-24

Last Posted Date: 2025-03-04

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 300

Registration Number: NCT06842966

Locations: 🇷🇺
State autonomous health care institution "Engels City Clinical Hospital No. 1", Engels, Russian Federation
🇷🇺
Ivanovo Kuvaev Clinical Hospital, Ivanovo, Russian Federation
🇷🇺
State Budgetary Institution of Healthcare of Moscow "City Polyclinic No. 2 of the Moscow Department of Healthcare", Moscow, Russian Federation

and more 14 locations

Study to Evaluate the Efficacy and Safety of Using Different Doses of Graminidin With Anesthetic for the Treatment of Acute Infectious-inflammatory Diseases of the Pharynx in Comparison With Septolete Total, Lozenges

Phase 2

Recruiting

Conditions: Pharyngitis Acute
Pharyngitis
Nasopharyngitis
Exacerbation of Chronic Pharyngitis

Interventions: Drug: Grammidin with anesthetic
Drug: Septolete Total

First Posted Date: 2025-02-24

Last Posted Date: 2025-03-04

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 300

Registration Number: NCT06843018

Locations: 🇷🇺
State autonomous health care institution "Engels City Clinical Hospital No. 1", Engels, Russian Federation
🇷🇺
State Budgetary Healthcare Institution of the Kaliningrad Region "City Hospital No. 2.", Kaliningrad, Russian Federation
🇷🇺
Unimed-C Jsc, Moscow, Russian Federation

and more 9 locations

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Not Applicable

Completed

Conditions: Symptomatic Treatment of Gastric and Duodenal Ulcers
Heartburn
Acid-dependent Diseases of the Gastrointestinal Tract

Interventions: Drug: Magaldrate

First Posted Date: 2024-08-14

Last Posted Date: 2024-08-14

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 40

Registration Number: NCT06552624

Locations: 🇷🇺
Limited Liability Company "Research Center Eco-Safety", Saint Petersburg, Russian Federation
🇷🇺
Llc "Certa Clinic", Moscow, Russian Federation
🇷🇺
Private Health Care Institution "Clinical Hospital "RZD-Medicine" of St. Petersburg, Saint Petersburg, Russian Federation

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

Phase 3

Recruiting

Conditions: Acute Respiratory Infection

Interventions: Drug: XC8
Drug: Placebo

First Posted Date: 2024-04-23

Last Posted Date: 2024-04-23

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 252

Registration Number: NCT06379542

Locations: 🇷🇺
PiterKlinika LLC, Saint Petersburg, Russian Federation
🇷🇺
City Pediatric Outpatient Clinic number 5, Perm, Russian Federation
🇷🇺
ArsVite North-West, LLC, Saint Petersburg, Russian Federation

and more 3 locations

Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin

Phase 1

Completed

Conditions: Nausea

Interventions: Drug: Doxylamine + Pyridoxine
Drug: Diclectin

First Posted Date: 2024-04-02

Last Posted Date: 2025-02-19

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 28

Registration Number: NCT06342778

Locations: 🇷🇺
State budgetary health care institution Yaroslavl region "Clinical Hospital № 3", Yaroslavl, Russian Federation

Food Effect on the Bioavailability of 4-MUST, Tablets, 128 mg

Phase 1

Recruiting

Conditions: Cholecystitis

Interventions: Drug: 4-MUST, 2 tablets, fasted
Drug: 4-MUST, 2 tablets, after meals

First Posted Date: 2024-04-02

Last Posted Date: 2024-04-02

Lead Sponsor: Valenta Pharm JSC

Target Recruit Count: 24

Registration Number: NCT06342804

Locations: 🇷🇺
Federal Budgetary Institution of Science "North-Western Scientific Center for Hygiene and Public Health", Saint Petersburg, Russian Federation

Home Terms & Conditions Privacy Policy